Legal Opinion
In re Warfarin Sodium Antitrust Litigation
District Court, D. Delaware
Decided August 30, 2002No. MDL 98-1232-SLRPublishedCited by 48 opinions
1Opinion of the Court
OPINION
SUE L. ROBINSON, Chief Judge.
1. INTRODUCTION
On March 30, 2001, consumers and third-party payors (“TPPs”) who paid all or part of the purchase price of Coumadin® warfarin sodium1 filed a consolidated class action complaint alleging, individually and on behalf of all others similarly situated, that defendant DuPont Pharmaceuticals Company2 (“DuPont”) caused them to overpay for Coumadin as a result of defendant’s anticom-petitive behavior and dissemination of false and misleading information about Coumadin and its generic competitor. (D.I.163) Plaintiffs alleged violations of federal and…
2Cases cited42 opinions
- Amchem Products, Inc. v. WindsorSupreme Court of the United States · 1997
- Eisen v. Carlisle & JacquelinSupreme Court of the United States · 1974
- United States v. Grinnell Corp.Supreme Court of the United States · 1966
- Phillips Petroleum Co. v. ShuttsSupreme Court of the United States · 1985
- City of Detroit v. Grinnell Corporation, Manhattan-Ward, Incorporated v. Grinnell Corporation, 1225 Vine Street Building, Inc. v. Grinnell CorporationCourt of Appeals for the Second Circuit · 1974
37 more not listed; retrieve them via the Exa API.
3Cited by48 opinions
- Sullivan v. DB Investments, Inc.Court of Appeals for the Third Circuit · 2011
- In re Cardizem CD Antitrust LitigationDistrict Court, E.D. Michigan · 2003
- In Re Chocolate Confectionary Antitrust LitigationDistrict Court, M.D. Pennsylvania · 2009
- Barbosa v. Cargill Meat Solutions Corp.District Court, E.D. California · 2013
- O'Keefe v. Mercedes-Benz USA, LLCDistrict Court, E.D. Pennsylvania · 2003
43 more not listed; retrieve them via the Exa API.